End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
99.16 CHF | +0.28% |
|
+2.04% | +1.47% |
01-10 | BNP Paribas Exane Upgrades DSM-Firmenich to Outperform, Raises PT | MT |
01-09 | Stifel Upgrades DSM-Firmenich to Buy, Lifts PT | MT |
Evolution of the Average Target: DSM-Firmenich
Evolution of the Target Price: DSM-Firmenich
Changes in Analyst Recommendations: DSM-Firmenich
Analyst Opinion | 4m Revision of opinion | Divergence of analysts' opinions | Divergence of Target Price | Ecart obj. / dr | ||
---|---|---|---|---|---|---|
+29.25% | ||||||
+6.29% | ||||||
+8.63% | ||||||
+1.56% | ||||||
+1.16% | ||||||
+19.08% | ||||||
+11.66% | ||||||
- | - | - | +4.80% | |||
+16.38% | ||||||
Average | +10.98% | |||||
Weighted average by Cap. | +7.05% |
Analysts' Consensus
![Consensus](https://cdn.zonebourse.com/images/consensus_flch.gif)
Analyst Consensus Detail
Consensus revision (last 18 months)
Analysts covering the company
BNP Paribas | |
Stifel Nicolaus | |
alphavalue | Martin Schnee |
Kepler Cheuvreux |
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- DSFIR Stock
- Consensus DSM-Firmenich
![United States](/images/png-country/24x24/us.png)
MarketScreener is also available in this country: United States.
Switch edition